In addition, aCLL patients demonstrated a higher expression of CD23, but no significant difference was noted between aCLL and classic CLL regarding the expression of surface immunoglobulin (sIg), CD79b, or CD5. Here, CD79B is linked to B-cell chronic lymphocytic leukemia.